Analgesic and adjuvant co‐prescribing in Australian and Finnish residential care homes
Australasian Journal on Ageing · 2025
DOI: 10.1111/ajag.70062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australasian Journal on Ageing, 2025. Verfasst von Laura A Dowd und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medicine Use and Safety (CMUS), Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Analgesics, Practice Patterns, Physicians', Nursing Homes, Homes for the Aged. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University, National Health and Medical Research Council, Department for Innovation and Skills, Government of South Australia.
Abstract (Originalsprache)
Objective
To explore the co‐prescribing of analgesic and/or adjuvant medications among residents of Australian and Finnish residential care homes.
Method
Secondary cross‐sectional analyses of prescribing data from residents of 12 Australian residential care homes in 2019 and 53 Finnish nursing homes and assisted living facilities in 2017–2018. Demographic characteristics and medication data were extracted from medical records and medication administration charts. Co‐prescribing was defined as more than one analgesic (acetaminophen, non‐steroidal anti‐inflammatory drugs and opioids) and/or adjuvant (gabapentinoids, tricyclic antidepressants and duloxetine) medication prescribed for regular administration.
Results
Overall, 550 Australian residents (89 [IQR 84–92] years; 73% females) and 2423 Finnish residents (84 [IQR 65–103] years; 74% females) were included. Of 416 Australian residents prescribed any regular analgesic or adjuvant, 181 (44%) were prescribed two or more, including 66 (16%) who were prescribed three or more. Of 1406 Finnish residents prescribed any regular analgesic or adjuvant, 469 (33%) were prescribed two or more, including 87 (6%) who were prescribed three or more. Acetaminophen was co‐prescribed to more than 75% of Australian and 43% of Finnish residents prescribed other analgesics or adjuvants. Of 61 Australian residents and 186 Finnish residents prescribed gabapentinoids, 38 (62%) and 86 (46%) were co‐prescribed opioids. Opioids were co‐prescribed to 59%–83% of Australian and 25%–46% of Finnish residents prescribed adjuvants.
Conclusions
Analgesic and adjuvant co‐prescribing was more prevalent for Australian than Finnish residents, which was largely driven by acetaminophen co‐prescribing to more than three quarters of analgesic or adjuvant users in Australia. Central nervous system‐active polypharmacy arising from high rates of adjuvant and opioid co‐prescribing warrants further attention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Medicine Use and Safety (CMUS), Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
- Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland.
- Unit of Primary Health Care, Helsinki University Hospital, Helsinki, Finland.
- Adelaide Geriatrics Training and Research with Aged Care (GTRAC) Centre, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
- The Basil Hetzel Institute, The Queen Elizabeth Hospital, Central Adelaide Local Health Network, Adelaide, South Australia, Australia.
- Department of Geriatrics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
ORCID-Profile: Laura A Dowd, Agathe D Jadczak, Renuka Visvanathan, Shin J Liau, Amanda J Cross
Förderung
- Monash University
- National Health and Medical Research Council
- Department for Innovation and Skills, Government of South Australia
- Hospital Research Foundation
- Australian Government Research Training Program Scholarship
- Healthy Aging Research Consortium
- South Australian Department for Innovation and Skills
- Resthaven Inc
Zitieren
APA
Dowd, L. A., Pitkälä, K. H., Jadczak, A. D., Roitto, H. M., Aalto, U. L., Saarela, R. K. T., Visvanathan, R., Liau, S. J., Cross, A. J., & Bell, J. S. (2025). Analgesic and adjuvant co‐prescribing in Australian and Finnish residential care homes. Australasian Journal on Ageing. https://doi.org/10.1111/ajag.70062
Vancouver
Dowd LA, Pitkälä KH, Jadczak AD, Roitto HM, Aalto UL, Saarela RKT, et al. Analgesic and adjuvant co‐prescribing in Australian and Finnish residential care homes. Australasian Journal on Ageing. 2025. doi:10.1111/ajag.70062
BibTeX
@article{Dowd2025,
author = {Dowd, Laura A and Pitkälä, Kaisu H and Jadczak, Agathe D and Roitto, Hanna-Maria and Aalto, Ulla L and Saarela, Riitta K T and Visvanathan, Renuka and Liau, Shin J and Cross, Amanda J and Bell, J Simon},
title = {Analgesic and adjuvant co‐prescribing in Australian and Finnish residential care homes},
journal = {Australasian Journal on Ageing},
year = {2025},
doi = {10.1111/ajag.70062}
}
EUVIMED